Definitive Contract 75D30122C15492
Award Date
9/30/22
Potential Completion Date
4/22/25
Potential Value
$2.2M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
University System Of Maryland
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,488,107.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Tetracore, Inc., a small business based in Rockville, Maryland. The contract is for the Phase II development of a rapid molecular assay for the point-of-care detection of Treponema pallidum, the causative agent of syphilis. This contract was awarded under the Small Business Innovation...
This is a $3,127,962.24 cost-plus-fixed-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) on September 15, 2003. The contract, which does not have a set-aside designation, is for "UNIV-MD/SPCMN COLLCT'N" and is scheduled to be completed by March 31, 2010. UMB, the prime contractor, is a major public research university that frequently receives federal funding through contracts and grants to support its...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) to provide AR Sentinel Site Surveillance for AR Organisms. The $99,990.00 Firm Fixed Price Delivery Order was placed under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The work is to be performed in Baltimore, MD. UMB serves as the prime contractor on this...
This firm fixed price delivery order for approximately $180,000 was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to the University of Maryland, Baltimore (UMB) for Sentinel Surveillance of Organisms that can Cause Healthcare-Associated Infections. The contract is being performed under the Safe Healthcare, Epidemiology, and Prevention Research Development Program (SHEPheRD) indefinite-delivery/indefinite-quantity master contract vehicle. UMB will conduct surveillance...
This is a $82,000 Delivery Order awarded to the University of Maryland, Baltimore (UMB) by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The contract is issued under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Vehicle (IDV) and has a firm fixed price arrangement. The contract is focused on the SHEPHERD 2021 DOMAIN 1-A010 SENTINEL requirement, which does not have a set-aside designation. As a...
This federal contract award, issued by the Centers for Disease Control and Prevention (CDC), tasks the University of Maryland, Baltimore (UMB) to conduct systems serology and cellular marker studies as part of a controlled human infection model (CHIM) trial for pertussis. Under this $1,160,383 firm-fixed-price definitive contract, UMB will perform a range of antibody profiling assays on samples from 30 adult participants before and after pertussis challenge. The data generated will then be...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $518,790.00 firm fixed price definitive contract to the University of Maryland, Baltimore for the "Transfer of Antibiotic-Resistant Bacteria" project. This contract does not have a set-aside designation. The University of Maryland, Baltimore is the prime contractor and is a U.S. state government, educational institution, and state-controlled institution of higher learning. The parent...
This is a $750,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, College Park (UMD) to support the agency's FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research efforts. The contract has a period of performance through March 30, 2024 and utilizes cost-reimbursement pricing with no fee. UMD is providing research, analysis, and other professional services related to the COVID-19 pandemic response. This award...
Tetracore, Inc. was awarded a $299,973 firm fixed price Small Business Innovation Research Phase I contract by the National Institute of Allergy and Infectious Diseases to develop a rapid molecular assay for point-of-care detection of Treponema pallidum. Work will be performed in Potomac, Maryland and involves research to create a new syphilis detection test with a faster turnaround time. As a small business, Tetracore specializes in assays and reagents for infectious disease detection and has...
This is a $6,279,477 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) for the collection of syphilis specimens. The contract has no set-aside designation. UNC-CH will serve as the prime contractor, while subcontractors include Duke University, Connecticut Children's Medical Center, and the University of Texas Health Science...